Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457469 · ClinicalTrials.gov registry record · Phase 1
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01457469: Completed Phase 1 study, sponsored by Wake Forest University Health Sciences.
NCT01457469 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01457469, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This randomized clinical trial studies enhanced quitline intervention in smoking cessation for patients with non-metastatic lung cancer. Stop-smoking plans suggested by doctors may help patients with early-stage cancer quit smoking
Primary Outcome
Participation rate will be calculated as the proportion of the eligible patients who agree to participate.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER counseling intervention
- OTHER internet-based intervention
- BEHAVIORAL telephone-based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
What the finished NCT01457469 record still lists
NCT01457469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01457469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01457469 about?
NCT01457469 is a clinical study titled "Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer". This randomized clinical trial studies enhanced quitline intervention in smoking cessation for patients with non-metastatic lung cancer. Stop-smoking plans suggested by doctors may help patients with early-stage cancer quit smoking
What is the current status of trial NCT01457469?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2011-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01457469?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), counseling intervention (OTHER), internet-based intervention (OTHER), telephone-based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01457469?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01457469's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia